| Mobile health for tuberculosis management in South India: is video-based directly observed treatment an acceptable alternative? AA Kumar, A De Costa, A Das, GA Srinivasa, G D'Souza, R Rodrigues JMIR mHealth and uHealth 7 (4), e11687, 2019 | 56 | 2019 |
| Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study Z Al‐Yafeai, M Ghoweba, A Ananthaneni, H Abduljabar, D Aziz British Journal of Clinical Pharmacology 89 (2), 641-648, 2023 | 8 | 2023 |
| Perceived usefulness of receiving a potential smoking cessation intervention via mobile phones among smokers in Indonesia MF Wibowo, AA Kumar, S Sumarsono, R Rodrigues Wellcome Open Research 4, 2019 | 8 | 2019 |
| Acceptability of video observed treatment vs. directly observed treatment for tuberculosis: a comparative analysis between South and central India JS Rao, V Diwan, AA Kumar, SS Varghese, U Sharma, M Purohit, A Das, ... Wellcome Open Research 7, 152, 2022 | 3 | 2022 |
| Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS) Z Al-Yafeai, M Sondhi, K Vadlamudi, R Vyas, D Nadeem, M Alawadi, ... International Journal of Cardiology, 131819, 2024 | 2 | 2024 |
| Cardiovascular complications of modern multiple myeloma therapy: analysis of FDA adverse event reporting system Z Al-Yafeai, A Ananthaneni, M Ghoweba, H Abduljabar, D Aziz, U Grewal MedRxiv, 2021.12. 20.21268138, 2021 | 2 | 2021 |
| Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study R Rodrigues, SS Varghese, M Mahrous, AA Kumar, MN Ahmed, ... BMJ open 13 (5), e065878, 2023 | 1 | 2023 |
| Vaccines and Atrial Fibrillation: A Real-World Pharmacovigilance Study Based on Vaccine Adverse Event Reporting System Z Al-Yafeai, M Ghoweba, D Aziz, A Ananthaneni, MD Sabayon American Journal of Therapeutics 30 (2), 151-153, 2023 | 1 | 2023 |
| Comparison of adverse event profiles of rituximab, rituximab hycela and rituximab biosimilars: a real-world pharmacovigilance database analysis D Keerty, A Ananthaneni, P Ramadas, SR Master Blood 140 (Supplement 1), 13196-13197, 2022 | 1 | 2022 |
| End of Life Care in Hospitalized Patients With Lung Cancer TS Brown, U Grewal, SR Thotamgari, AK Ananthaneni, C Burnett, ... International Journal of Radiation Oncology, Biology, Physics 112 (2), e18, 2022 | 1 | 2022 |
| ST SEGMENT ELEVATION IN CARDIAC METASTASIS FROM PRIMARY SQUAMOUS CELL CARCINOMA RM Sam, A Ananthaneni, S Sawyer, S Danciu, AJ Beall Journal of the American College of Cardiology 83 (13_Supplement), 4099-4099, 2024 | | 2024 |
| Adult‐onset Still's disease with concurrent thrombotic microangiopathy: Observations from pooled analysis for an uncommon finding A Ananthaneni, G Shimkus, F Weis, E Adu‐Dapaah, R Lakra, P Ramadas, ... European Journal of Haematology 112 (4), 484-492, 2024 | | 2024 |
| Are We Diagnosing and Managing Diabetes in Patients with Sickle Cell Disorders Accurately? A Ananthaneni, N Walker, R Vyas, F Weis, D Heap, S Chowdary, N Alva, ... Blood 142, 2301, 2023 | | 2023 |
| Immunosuppressant Drug-Associated Non-Hodgkin Lymphoma: A Real-World Pharmacovigilance Database Analysis A Ananthaneni, D Heap, F Weis, S Chowdary, R Sam, Z Al-Yafeai, ... Blood 142 (Supplement 1), 6268-6268, 2023 | | 2023 |
| Esophageal squamous cell carcinoma at the site of tracheo-esophageal fistula repair in a patient with cystic fibrosis AP Vyas, A Ananthaneni, S Abdehou, S Pandit BMJ Case Reports CP 16 (8), e253542, 2023 | | 2023 |
| Marginal zone lymphoma-associated membranous nephropathy: a rare presentation R Lakra, B Zoshchuk, A Ananthaneni, P Ramadas QJM: An International Journal of Medicine 116 (7), 551-552, 2023 | | 2023 |
| Unusual case of pernicious anaemia masquerading as thrombotic thrombocytopenic purpura in the setting of multiple normal vitamin B12 deficiency parameters: preventing anchoring … Z Mohammad, A Ananthaneni, A Fontenot, P Ramadas, M Nour Salloum Family Practice, cmad065, 2023 | | 2023 |
| Real-world analysis of cardiac, gastrointestinal, and hematologic toxicities between commonly used antiemetics in everyday oncology clinical practice. K Beedupalli, A Ananthaneni, D Findakly Journal of Clinical Oncology 41 (16_suppl), 6587-6587, 2023 | | 2023 |
| Bortezomib-induced cardiotoxicity: Real-world data from a single-center. SS Chennapragada, A Ananthaneni, S Sharma, SP Devarashetty, R Shi, ... Journal of Clinical Oncology 41 (16_suppl), e20008-e20008, 2023 | | 2023 |
| Characterization of Thrombosis After Vaccination: Analysis of The United States Vaccine Adverse Event Reporting System AC Gonzalez, Z Al-yafeai, A Kasabali, M Ghoweba, A Ananthaneni, ... Authorea Preprints, 2023 | | 2023 |
